Pre-operative Inspiratory Muscle Training Program to Prevent Pulmonary Complications After Thoracic Surgery
NCT ID: NCT03747380
Last Updated: 2023-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
141 participants
INTERVENTIONAL
2019-01-07
2022-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Inspiratory Muscle Training After Lung Cancer Surgery, a Randomized Controlled Trial
NCT01793155
Effects of Respiratory Muscle Training on Postoperative Pulmonary Complications of Cardiac Surgery
NCT03094923
Inspiratory Muscle Training in Lung Transplant Candidates
NCT06370832
Effects of Inspiratory Muscle Training in Patients With Advanced Lung Disease
NCT03511287
Effectiveness of Respiratory Muscle Training with a Mobile Application After Lobectomy
NCT06813144
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In order to reduce the pulmonary complications, other surgical specialties, such as cardiac and esophagus surgeries, use preoperative inspiratory muscle training programs. No study investigates the impact of preoperative inspiratory muscle exercises program on pulmonary complications after thoracic surgery.
Project Design:
Randomized study on patients at-risk of pulmonary complications. Two parallel groups are recruited for comparison between preoperative inspiratory muscle training program and the standard of care (without preoperative inspiratory muscle training program). In the study, 2 groups of 100 patients each are recruited in thoracic clinic. A recruitment period of approximately 8 months is needed in order to establish if the inspiratory muscular training significantly reduce the pulmonary complications in the patients at-risk. The P. value to determine a significant impact is 0.05 with a power of 0.80. We aim to reduce pulmonary complications with the inspiratory muscle training program by 50%.
Randomization Method:
Computerized, secure and anonymous randomization using a secure information program.
Population under study:
Recruitment in thoracic clinic, during the initial consultation for a thoracic surgery in the department of thoracic surgery of the University of Montreal Hospital Center, of a total of 200 patients. One hundred patients in the preoperative inspiratory muscle training group and 100 patients in the control group with usual care preoperatively (standard of care).
The study population is at-risk of pulmonary complications patients. The risk factors of pulmonary complications are patients over 70 years, presence of cough and sputum, diabetes, active smoking, FEV1 (forced expiratory volume per second) less than 75% or under respiratory pump, body mass index over 27 kg / m2, FEV1 less than 80%, Tiffeneau index less than 70%, NYHA II (New York Heart Association Classification) or sleep apnea.
Analysis A comparison of pulmonary complications after surgery in patients who participated in the inspiratory muscle training program and a control group who will have the usual care of a postoperative thoracic surgery.
After surgery, perioperative follow-up including perioperative complications, duration of hospitalization and complications and mortality after 30 days of surgery.
Satisfaction and motivation will be assessed postoperatively at discharge and at 30-day postoperative follow-up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
inspiratory muscle program
Inspiratory muscle training preoperative with standard of care
inspiratory muscle program
pre-operative inspiratory muscular training program
no inspiratory muscle program
standard of care: postoperative spirometry with enhanced recovery program in thoracic surgery
inspiratory muscle program
pre-operative inspiratory muscular training program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
inspiratory muscle program
pre-operative inspiratory muscular training program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pulmonary resection: segmental resection or lobectomy or bilobectomy
* With or without previous pulmonary resection
* Thoracotomy and minimally invasive surgery
* With or without neoadjuvant chemotherapy
* 1 or more risk factors for pulmonary complications (over 70 years, cough and sputum, diabetes, smoking, FEV1 less than 75% or under pump, BMI over 27 kg / m2, FEV1 less than 80%, TIFF less than 70%, NYHA II or sleep apnea)
Exclusion Criteria
* Pregnancy
* Pneumonectomy
* FEV1 less than 30%
* DLCO less than 30%
* Vo2 MAX less than 10cc / min / kg
* Contraindication to respiratory physiotherapy - Myocardial infarction or cerebrovascular accident for less than 1 year, unstable angina, aneurysm, significant hemoptysis less than 90 days, muscular or neurological pathology constraining respiratory physiotherapy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Moishe Liberman, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHUM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHUM
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-7755
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.